RetinAI specializes in AI-powered software solutions designed to enhance data management and analysis in ophthalmology. Their flagship platform, Discovery, enables healthcare professionals to efficiently manage and interpret ophthalmic data, facilitating improved patient outcomes.
By integrating advanced AI algorithms, RetinAI streamlines clinical workflows, supports teleophthalmology, and aids in precise decision-making.
The Discovery platform is versatile, catering to the needs of ophthalmologists, optometrists, and researchers. It harmonizes and analyzes large datasets, including OCT and fundus images, providing real-time insights through AI-driven analytics.
Features like Discovery Passport enhance patient engagement by securely sharing data and remote questionnaires. RetinAI’s commitment to innovation is evident through collaborations aimed at advancing treatments for retinal diseases, such as geographic atrophy.
